Serotype-Independent Protection Against Invasive Pneumococcal Infections Conferred by Live Vaccine With lgt Deletion
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jang, A-Yeung | - |
dc.contributor.author | Ahn, Ki Bum | - |
dc.contributor.author | Zhi, Yong | - |
dc.contributor.author | Ji, Hyun-Jung | - |
dc.contributor.author | Zhang, Jing | - |
dc.contributor.author | Han, Seung Hyun | - |
dc.contributor.author | Guo, Huichen | - |
dc.contributor.author | Lim, Sangyong | - |
dc.contributor.author | Song, Joon Yong | - |
dc.contributor.author | Lim, Jae Hyang | - |
dc.contributor.author | Seo, Ho Seong | - |
dc.date.accessioned | 2021-09-01T14:47:53Z | - |
dc.date.available | 2021-09-01T14:47:53Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2019-05-29 | - |
dc.identifier.issn | 1664-3224 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/65362 | - |
dc.description.abstract | Streptococcus pneumoniae is the most common respiratory bacterial pathogen among cases of community-acquired infection in young children, older adults, and individuals with underlying medical conditions. Although capsular polysaccharide-based pneumococcal vaccines have contributed to significant decrease in invasive pneumococcal infections, these vaccines have some limitations, including limited serotype coverage, lack of effective mucosal antibody responses, and high costs. In this study, we investigated the safety and immunogenicity of a live, whole-cell pneumococcal vaccine constructed by deleting the gene for prolipoprotein diacylglyceryl transferase (lgt) from the encapsulated pneumococcal strain TIGR4 (TIGR4 Delta lgt) for protection against heterologous pneumococcal strains. Pneumococcal strain TIGR4 was successfully attenuated by deletion of lgt, resulting in the loss of inflammatory activity and virulence. TIGR4 Delta lgt colonized the nasopharynx long enough to induce strong mucosal IgA and IgG2b-dominant systemic antibody responses that were cross-reactive to heterologous pneumococcal serotypes. Finally, intranasal immunization with TIGR4 Delta lgt provided serotype-independent protection against pneumococcal challenge in mice. Taken together, our results suggest that TIGR4 Delta lgt is an avirulent and attractive broad-spectrum pneumococcal vaccine candidate. More broadly, we assert that modulation of such "master" metabolic genes represents an emerging strategy for developing more effective vaccines against numerous infectious agents. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | FRONTIERS MEDIA SA | - |
dc.subject | DIACYLGLYCERYL TRANSFERASE LGT | - |
dc.subject | STREPTOCOCCUS-PNEUMONIAE | - |
dc.subject | LIPOTEICHOIC ACID | - |
dc.subject | NASOPHARYNGEAL COLONIZATION | - |
dc.subject | INFLAMMATORY RESPONSES | - |
dc.subject | BACTERIAL LIPOPROTEINS | - |
dc.subject | ESCHERICHIA-COLI | - |
dc.subject | IMMUNE-RESPONSES | - |
dc.subject | DISEASE | - |
dc.subject | PROTEIN | - |
dc.title | Serotype-Independent Protection Against Invasive Pneumococcal Infections Conferred by Live Vaccine With lgt Deletion | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Song, Joon Yong | - |
dc.identifier.doi | 10.3389/fimmu.2019.01212 | - |
dc.identifier.scopusid | 2-s2.0-85068104370 | - |
dc.identifier.wosid | 000469434900001 | - |
dc.identifier.bibliographicCitation | FRONTIERS IN IMMUNOLOGY, v.10 | - |
dc.relation.isPartOf | FRONTIERS IN IMMUNOLOGY | - |
dc.citation.title | FRONTIERS IN IMMUNOLOGY | - |
dc.citation.volume | 10 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Immunology | - |
dc.relation.journalWebOfScienceCategory | Immunology | - |
dc.subject.keywordPlus | DIACYLGLYCERYL TRANSFERASE LGT | - |
dc.subject.keywordPlus | STREPTOCOCCUS-PNEUMONIAE | - |
dc.subject.keywordPlus | LIPOTEICHOIC ACID | - |
dc.subject.keywordPlus | NASOPHARYNGEAL COLONIZATION | - |
dc.subject.keywordPlus | INFLAMMATORY RESPONSES | - |
dc.subject.keywordPlus | BACTERIAL LIPOPROTEINS | - |
dc.subject.keywordPlus | ESCHERICHIA-COLI | - |
dc.subject.keywordPlus | IMMUNE-RESPONSES | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | PROTEIN | - |
dc.subject.keywordAuthor | Streptococcus pneumoniae | - |
dc.subject.keywordAuthor | Lgt | - |
dc.subject.keywordAuthor | lipoprotein | - |
dc.subject.keywordAuthor | live attenuated vaccine | - |
dc.subject.keywordAuthor | mucosal immunity | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.